Xue Song

机构：Zhejiang Chinese Medical University, Shanghai Jiao Tong University, Dalian University of Technology, Renji Hospital, Institut Gustave Roussy, Dalian University, Simcere Pharmaceutical (China), Fourth People’s Hospital of Jinan, Jiangsu Cancer Hospital, First Affiliated Hospital of Henan University of Science and Technology, Xian Yang Central Hospital, Aspects métaboliques et systémiques de l'oncogénèse pour de nouvelles approches thérapeutiques, Nanjing Medical University · ORCID：0000-0002-9305-9161

发表论文 162 篇 · 总被引 3014 次 · h-index 29

代表论文

• Potential predictive biomarkers in antitumor immunotherapy: navigating the future of antitumor treatment and immune checkpoint inhibitor efficacy (2024 · Frontiers in Oncology · 被引 40)
• Prediction of Patients With High-Risk Osteosarcoma on the Basis of XGBoost Algorithm Using Transcriptome and Methylation Data From SGH-OS Cohort (2025 · JCO Precision Oncology · 被引 9)
• Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system (2025 · Frontiers in Pharmacology · 被引 6)
• Adrenomedullin Inhibits the Efficacy of Combined Immunotherapy and Targeted Therapy in Biliary Tract Cancer by Disrupting Endothelial Cell Functions (2025 · Journal of Cellular and Molecular Medicine · 被引 5)
• Genetic and clinical characteristics of genetic tumor syndromes in the central nervous system cancers: Implications for clinical practice (2024 · iScience · 被引 5)
• A survey of breastfeeding among women with previous surgery for benign breast disease: a descriptive exploratory study (2024 · International Breastfeeding Journal · 被引 5)